Home > Boards > US Listed > Biotechs > Enochian Biosciences Inc. (ENOB)

DDRT buy 3.30

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 474
Posts 10,133
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/13/2021 8:16:28 AM
Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference GlobeNewswire Inc. - 9/13/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/30/2021 1:35:52 PM
Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences’ Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants GlobeNewswire Inc. - 8/30/2021 7:00:00 AM
Distinguished Scientific and Clinical Leader to Join Enochian BioSciences’ Hepatitis B Cure Scientific Advisory Board GlobeNewswire Inc. - 8/23/2021 10:18:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2021 4:29:37 PM
Enochian BioSciences picks Hon. Dr. Mark Dybul as CEO Seeking Alpha - 7/20/2021 7:54:21 AM
Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer GlobeNewswire Inc. - 7/20/2021 7:00:00 AM
Enochian Biosciences shares rise after FDA accepts hepatitis treatment Pre-IND request Seeking Alpha - 7/12/2021 7:44:09 AM
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection GlobeNewswire Inc. - 7/12/2021 7:00:00 AM
Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity GlobeNewswire Inc. - 6/30/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2021 11:50:27 AM
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treat... GlobeNewswire Inc. - 6/21/2021 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/16/2021 4:10:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/16/2021 8:50:34 AM
Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV PR Newswire (US) - 6/15/2021 9:05:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/14/2021 5:16:29 PM
Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/14/2021 2:53:19 PM
Enochian Biosciences shares skyrocket after FDA accepts Pre-IND request for HIV treatment Seeking Alpha - 6/14/2021 8:09:38 AM
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure GlobeNewswire Inc. - 6/14/2021 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/17/2021 4:46:46 PM
Enochian Bio reports preliminary data from HIV cell therapy in humans Seeking Alpha - 5/12/2021 9:57:30 AM
A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference... PR Newswire (US) - 5/12/2021 8:05:00 AM
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 2... GlobeNewswire Inc. - 5/12/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/22/2021 5:02:41 PM
stocktrademan   Saturday, 12/02/17 01:55:42 PM
Re: None
Post # of 22 
DDRT buy 3.30

bull flag
inverted head and shoulders bottom

DanDrit Biotech USA, Inc.

U.S. Office
375 Park Avenue, Suite 2607
New York, NY, 10152
United States
Phone: +1 (212) 763 0184

Danish Office
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark

Lab Facilities
DanDrit Biotech A/S
Symbion Science Park
Fruebjergvej 3, Box 62
2100 Copenhagen
Denmark

http://www.dandrit.com
https://mytomorrows.com/en/

DanDrit Biotech USA, Inc. is focusing on the clinical development of a dendritic cell vaccine for treatment of colorectal cancer. DanDrit Biotech A/S was founded in 2001 on the research of Professor Jesper Zeuthen at the Danish Cancer Society (Kraeftens Bekaempelse). Dendritic cells are critical components of the immune system. The ability of dendritic cells to induce a strong immune response is the basis of the vaccine therapies under development at DanDrit. Our expertise in producing dendritic cells from a patient’s blood is combined with conventional production methods to make new and advanced vaccines for cancer patients.

The proprietary technology upon which MCV is based is protected by several issued patents.

Also based on a 2011 Nobel Prize for research on dendritic cells.

normal chart




log chart





Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences